Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease
Issued Date
2022-03-01
Resource Type
ISSN
24058440
Scopus ID
2-s2.0-85127004416
Journal Title
Heliyon
Volume
8
Issue
3
Rights Holder(s)
SCOPUS
Bibliographic Citation
Heliyon Vol.8 No.3 (2022)
Suggested Citation
Jirasirirak S., Disthabanchong S., Ongphiphadhanakul B., Arj-Ong Vallibhakara S., Nimitphong H. Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease. Heliyon Vol.8 No.3 (2022). doi:10.1016/j.heliyon.2022.e09158 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/86595
Title
Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease
Other Contributor(s)
Abstract
Objective: This study aimed to investigate the prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease undergoing hemodialysis. Methods: This cross-sectional study included 80 patients with end-stage renal disease undergoing hemodialysis. Medical history, Fracture Risk Assessment Tool and anteroposterior and lateral radiographs of the thoracolumbar and lumbosacral spine were obtained. Vertebral fractures were identified using the Genant semiquantitative assessment. Results: Radiography demonstrated asymptomatic vertebral fracture in 22 patients (27.5%). FRAX® results for major osteoporotic fracture (area under the curve, 0.64) and hip fracture (area under the curve, 0.62) were able to discriminate patients with prevalent asymptomatic vertebral fracture. A multivariate analysis demonstrated that a 1-year average corrected calcium (odds ratio, 0.38), steroid use (odds ratio, 8.99), and a serum albumin concentration <25 g/dL (odds ratio, 28.82) significantly predicted prevalent asymptomatic vertebral fracture (clinical model; area under the curve, 0.82). Combining the 1-year average corrected calcium and serum albumin concentration <25 g/dL with FRAX® results for major osteoporotic fracture (area under the curve, 0.78) and FRAX® results for hip (area under the curve, 0.75) produced a significantly greater area under the curve value to predict fracture when compared with FRAX® result for major osteoporotic fracture and FRAX® result for hip (P = 0.022). Conclusion: Asymptomatic vertebral fracture is prevalent. FRAX® results for major osteoporotic fracture and hip provided lower ability in predicting asymptomatic vertebral facture when compared to the clinical model. Combining a 1-year average corrected calcium and serum albumin concentration <25 g/dL with FRAX® result for major osteoporotic fracture or hip improved the model's performance and provided comparable area under the curve to the clinical model.